Insider Trading & Ownership of Sanofi
-
Location
-
Paris, France
-
Summary
-
The estimated value of insider holdings of Sanofi is at least $3,002,412,171 dollars as of 13 Aug 2024. Sanofi is the 10%+ Owner of Translate Bio, Inc. and owns shares of Translate Bio, Inc. stock worth about $2.88B. Sanofi is the 10%+ Owner of MeiraGTx Holdings plc and owns shares of MeiraGTx Holdings plc (MGTX) stock worth about $77.58M. Sanofi is the 10%+ Owner of Icosavax, Inc. and owns shares of Icosavax, Inc. stock worth about $49.45M.
-
Signature
-
/s/ Alexandra Roger, Alexandra Roger, Head of Legal Corporate & Finance
Follow Filing Activity
Follow Sanofi and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Quick Takeaways
- Sanofi has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,002,412,171.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: Translate Bio, Inc. ($2,875,385,178).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Sanofi
Insider Transactions Reported by Sanofi:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.